Lenvatinib plus pembrolizumab improved survival outcomes in advanced endometrial cancer
Uterine cancer is the second most prevalent Gynecological cancer in the world and it has high incidence rates in developed countries.
top of page
About
We are dedicated scientific professionals committed to synthesizing advances in sciences & practice of medicine into layman’s language (simple & understandable), without deviating from scientific facts. The role of Genomics and other omics (multi-omics) is our focus on improving quality of life.
Help
Get in touch
© 2024 by bhimar.org
bottom of page